<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antiphospholipid (Hughes') syndrome (APS) has not been reported in African-Americans (A-A) as frequently as in other ethnic groups </plain></SENT>
<SENT sid="1" pm="."><plain>We describe eight A-A female patients with APS, including two cases of primary APS (PAPS), four with APS secondary to <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), one with <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndrome</z:e>, and one with overlap <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> (CTD) </plain></SENT>
<SENT sid="2" pm="."><plain>Their mean age was 34 y (range 24-47 y) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were followed for a mean of 6 y (range 0.3-11 y) </plain></SENT>
<SENT sid="4" pm="."><plain>During follow up, both anticardiolipin (aCL) and anti-beta2glycoprotein-I (abeta2GPI) antibodies were measured in stored sera by enzyme-linked immunosorbent assay (ELISA) </plain></SENT>
<SENT sid="5" pm="."><plain>IgA was the most frequent isotype of aCL and abeta2GPI, and co-occurred with the IgM isotype in three of four patients with neurologic manifestations </plain></SENT>
</text></document>